Depletion of cytosolic phospholipase A 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis

Cancer Research

Volumn 69, Issue 5, 2009, Pages 1733-1738

  Weiser Evans, Mary C M ^a   Wang, Xue Qing ^a   Amin, Jay ^a   Van Putten, Vicki ^a   Choudhary, Rashmi ^a   Winn, Robert A ^b   Scheinman, Robert ^b   Simpson, Peter ^a   Geraci, Mark W ^b   Nemenoff, Raphael A ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOLIC PHOSPHOLIPASE A2; INTERLEUKIN 6; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CANCER CELL; CANCER GROWTH; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; KNOCKOUT MOUSE; LUNG CANCER; MACROPHAGE; MEDIASTINUM LYMPH NODE; METASTASIS; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN DEPLETION; STAINING; TUMOR GROWTH; WILD TYPE; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; DISEASE COURSE; ENZYMOLOGY; FEMALE; HUMAN; LUNG TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BONE MARROW CELLS; CELL LINE, TUMOR; DINOPROSTONE; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MACROPHAGES; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; PHOSPHOLIPASES A2, CYTOSOLIC;

EID: 62449343121     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3766     Document Type: Article

References (20)

1. Kenny PA, Lee GY, Bissell MJ. Targeting the tumor microenvironment. Front Biosci 2007;12:3468-3474.
2. Heasley LE, Thaler S, Nicks M, Price B, Skorecki K, Nemenoff RA. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J Biol Chem 1997;272:14501-14504.
3. Meyer AM, Dwyer-Nield LD, Hurteau GJ, et al. Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis 2004;25:1517-1524.
4. Riches DW, Henson PM, Remigio LK, Catterall JF, Strunk RC. Differential regulation of gene expression during macrophage activation, with a polyribonucleotide. The role of endogenously derived IFN. J Immunol 1988;141:180-188.
5. Bonventre JV Huang Z, Taheri MR, et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 1997; 390:622-625.
6. Layton MG, Franks LM. Heterogeneity in a spontaneous mouse lung carcinoma: selection and characterisation of stable metastatic variants. BrJ Cancer 1984;49: 415-421.
7. Chen X, Su Y, Fingleton B, et al. An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alphal-null mice. Clin. Exp Metastasis 2005;22:185-193.
8. Onn A, Isobe T, Itasaka S, et al. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 2003;9:5532-5539.
9. Condeelis J, Pollard JW". Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-6.
10. Meyer AM, Dwyer-Nield LD, Hurteau G, et al. Attenuation, of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase A2 null mice. Am J Physiol Lung Cell MoI Physiol 2006;290:L1260-6.
11. Naugler WE, Karin. M. The wolf in sheep's clothing: the role of lnterleukln-6 in immunity, inflammation and cancer. Trends Mol Med 2008;14:109-119.
12. Hagemann T, Wilson J, Burke F, et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 2006;176:5023-5032.
13. Welsh TJ, Green. RH, Richardson D, Waller DA, O'Byrne KJ, Bradding P. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage In non-small-cell lung cancer. J Clin Oncol 2005;23:8959-8967.
14. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66:605-612.
15. Ancrile B, LIm K-H, Counter CM. Oncogenic Rasinduced secretion of IL6 is required for tumorigenesis. Genes Dev 2007;21:1714-1719.
16. Han C, Demetria AJ, Stolz DB, Xu L, Um K, Wu T. Modulation of Stati activation by the cytosolic phosphatase A2a and cycl.oox.ygenase-2-controlled prostaglandin E2 signaling pathway. J Biol Chem 2006:281: 24831-24846.
17. Harlzi H, Gualde N. Pivotal, role of PG.E2 and IL-IO in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell MoI Immunol 2006;3: 271-277.
18. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of Immunity. Trends Immunol 2002;23:144-150.
19. Slnha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007;179:977-983.
20. Riedl K, Krysan K, PoId M, et al. Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updat 2004;7:169-184.